Skip to content
OnDosis logo — OnDosis is revolutionizing the way patients take their medic...

OnDosis

OnDosis is revolutionizing the way patients take their medicines

Founded 2017 Sweden Sweden 41 employees Venture round Total: $122.07M Pharmaceutical

General Information

Company Name OnDosis
Founded Year 2017
Location Sweden Sweden
Employees 41
Industries Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with OnDosis. To contact OnDosis, visit ondosis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does OnDosis compare?

A PDF of OnDosis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting OnDosis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About OnDosis

OnDosis is a Swedish pharmaceutical startup aiming to revolutionize the way patients take their medicines. Founded in 2017 as a spin-out from AstraZeneca, the company's OnDosis Dosage Manager offers flexible and individualized dosing of oral medicines, targeting conditions such as ADHD, food allergies, pain, and immunosuppression for organ transplants. The company recently secured a kr92.00M Venture Round investment on 23 May 2021, with participation from DIG Investment, Aeternum Management, and Albonja. With its innovative approach to personalized medicine, OnDosis is poised to address significant unmet medical needs, potentially benefitting hundreds of thousands of patients worldwide.

Business keywords: Precision Medicine, Health Tech, Pharmaceuticals, Med Tech, ADHD, Pain Management, Immunosuppression, Pediatrics, Digital Health, Connected Health, Formulation, Personalized Medicine, Drug Delivery, Healthcare Innovation, Patient Adherence

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round kr92.00M 3
DIG Investment, Aeternum Management +1
23 May 2021
Seed Round kr30.00M 3
GU Ventures, DIG Investment +1
11 Sep 2020
Grant Undisclosed 1
Horizon 2020
15 Aug 2019
Grant €71.43K 1
EASME - EU Executive Agency for SMEs
01 Jan 2019

OnDosis Alternatives & Competitors

View All Alternatives
OnDosis vs

Developing innovative CNS and pain therapies that significantly address unmet medical needs.

Post-IPO Debt
201-500 employees
Biotechnology, Health Care
OnDosis vs
HealthMatch
HealthMatch Australia

Connecting People To Revolutionary Drugs And Potential Cures

Series C
24 employees
Biotechnology, Health Care
OnDosis vs
Archimedes Pharma
Archimedes Pharma United Kingdom

Specialty pharmaceutical company developing therapeutics for the treatment of chronic and debilitati...

Acquired
30 employees
Biotechnology, Health Care

FAQ About OnDosis

OnDosis is revolutionizing the way patients take their medicines
OnDosis was founded in 2017.
OnDosis is headquartered in Sweden.
OnDosis operates in Pharmaceutical. Its work centres on Precision Medicine, Health Tech, Pharmaceuticals and Med Tech.
OnDosis has approximately 41 employees.
OnDosis has completed 4 funding rounds, raising a total of $122.07M. The latest funding stage is Venture round.
Top alternatives and competitors to OnDosis include Zogenix, HealthMatch , Archimedes Pharma, Strategic Science & Technologies, Plumb Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OnDosis and Zogenix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for OnDosis, https://bouncewatch.com/company/ondosis, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout